Cellectar Biosciences Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CLRB Nasdaq 2834 http://cellectar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cellectar Biosciences Inc

Cellectar Biosciences (NASDAQ:CLRB) Is In A Good Position To Deliver On Growth Plans - Sep 24th, 2021 11:25 am
Cellectar Bio's Iopofosine Data Shows Favorable Safety Profile In Head & Neck Cancer - Sep 22nd, 2021 4:27 pm
Preliminary Data with Iopofosine I-131 in Combination with External Beam Radiation Suggests Safety and Tolerability in Relapsed or Refractory Head and Neck Cancer - Sep 22nd, 2021 12:30 pm
Cellectar to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Sep 15th, 2021 8:01 pm
4 Penny Stocks Insiders Are Buying - Sep 8th, 2021 12:44 pm
Cellectar Receives $2M NIH Grant For Rare Lymphoma Study - Aug 18th, 2021 3:54 pm
Cellectar Awarded $2.0 Million Phase II NIH SBIR Grant to Support Pivotal Study of Iopofosine I-131 in Waldenstrom’s Macroglobulinemia - Aug 18th, 2021 12:30 pm
Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131 - Aug 16th, 2021 12:30 pm
Cellectar Reports Financial Results for the Second Quarter 2021 and Provides a Corporate Update - Aug 9th, 2021 12:30 pm
Cellectar Announces Expansion of Ongoing Collaboration Agreement with IntoCell Inc. - Jul 13th, 2021 1:00 pm
Cellectar Announces a Co-Development and Commercialization Collaboration with LegoChemBio for New Small Molecule Phospholipid Drug Conjugates (PDCs) - Jul 12th, 2021 12:30 pm
Cellectar to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference - Jul 8th, 2021 12:30 pm
Cellectar Announces the Election of Dr. Asher Alban Chanan-Khan to Its Board of Directors - Jun 24th, 2021 12:30 pm
Cellectar Bio Stock Drops After ASCO Presentation on White Blood Cell Cancer Therapy - Jun 4th, 2021 7:13 pm
Cellectar Presents Data in Waldenstrom’s Macroglobulinemia in Poster at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting - Jun 4th, 2021 1:00 pm
Cellectar Announces Poster Presentation of CLR 131 Data in Waldenstrom’s Macroglobulinemia at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting - May 20th, 2021 12:30 pm
Cellectar to Participate at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021 - May 14th, 2021 1:00 pm
Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update - May 10th, 2021 12:30 pm
Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico - Apr 27th, 2021 12:39 pm
Are Insiders Buying Cellectar Biosciences, Inc. (NASDAQ:CLRB) Stock? - Mar 28th, 2021 8:29 am